Skip to main content
SpringerLink
Log in

Significance of Preoperative Systemic Inflammation Score in Short-Term and Long-Term Outcomes of Patients with Pathological T2–4 Gastric Cancer After Radical Gastrectomy

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Surgical resection is the mainstay of treatment for patients with gastric cancer (GC). Development of a simple, high-performance, integrated scoring system is needed to provide appropriate management. This study aimed to evaluate predictive values of the systemic inflammation score (SIS) for short- and long-term outcomes of patients who underwent surgery for GC.

Methods

A total of 187 patients who underwent gastrectomy for pT2–4 GC without preoperative treatment were analyzed. SIS was formulated based on serum albumin level and lymphocyte–monocyte ratio, and graded into SIS 0, 1, and 2.

Results

Preoperative SIS was significantly associated with incidence of postoperative complications, showing a stepwise increased incidence in proportion to SIS in the entire cohort and all subgroups according to operative procedure and disease stage. Overall and disease-free survival times of patients in SIS 0, 1, and 2 shortened in a stepwise fashion. SIS was linked to prevalence of hematogenous metastasis as initial recurrence site. Survival differences between patients with SIS 2 and the others were particularly large in patients who underwent adjuvant chemotherapy. The continuation rate of adjuvant S-1 was lower in the SIS 2 group.

Conclusion

SIS represents a simple predictor for incidence of postoperative complications and survival in patients with pT2–4 GC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Van Cutsem E, Sagaert X, Topal B et al (2016) Gastric cancer. Lancet 388:2654–2664

    Article  PubMed  CAS  Google Scholar 

  2. Kanda M, Mizuno A, Fujii T et al (2016) Tumor infiltrative pattern predicts sites of recurrence after curative gastrectomy for stages 2 and 3 gastric cancer. Ann Surg Oncol 23:1934–1940

    Article  PubMed  Google Scholar 

  3. Shen L, Shan YS, Hu HM et al (2013) Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol 14:e535–e547

    Article  PubMed  Google Scholar 

  4. Kurita N, Miyata H, Gotoh M et al (2015) Risk model for distal gastrectomy when treating gastric cancer on the basis of data from 33,917 Japanese patients collected using a nationwide web-based data entry system. Ann Surg 262:295–303

    Article  PubMed  Google Scholar 

  5. Kanda M, Tanaka C, Kobayashi D et al (2017) Proposal of the coagulation score as a predictor for short-term and long-term outcomes of patients with resectable gastric cancer. Ann Surg Oncol 24:502–509

    Article  PubMed  Google Scholar 

  6. Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454:436–444

    Article  PubMed  CAS  Google Scholar 

  7. Huang L, Liu S, Lei Y et al (2016) Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection. Oncotarget 7:44185–44193

    PubMed  PubMed Central  Google Scholar 

  8. Suzuki Y, Okabayashi K, Hasegawa H et al (2018) Comparison of preoperative inflammation-based prognostic scores in patients with colorectal cancer. Ann Surg 267:527–531

    Article  PubMed  Google Scholar 

  9. Chan JC, Chan DL, Diakos CI et al (2017) The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg 265:539–546

    Article  PubMed  Google Scholar 

  10. Chang Y, An H, Xu L et al (2015) Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma. Br J Cancer 113:626–633

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Sobin LH, Gospodarowicz MK, Wittekind C (2009) International Union Against Cancer, TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, New York

    Google Scholar 

  12. Japanese Gastric Cancer Association (2017) Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 20:1–19

    Article  Google Scholar 

  13. Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196

    Article  PubMed  Google Scholar 

  14. Kanda M, Murotani K, Kobayashi D et al (2015) Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: a propensity score matching analysis. Surgery 158:1573–1580

    Article  PubMed  Google Scholar 

  15. Sasako M, Sakuramoto S, Katai H et al (2011) Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29:4387–4393

    Article  PubMed  CAS  Google Scholar 

  16. Kanda M, Kobayashi D, Tanaka C et al (2016) Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer. Gastric Cancer 19:255–263

    Article  PubMed  CAS  Google Scholar 

  17. Kanda M, Shimizu D, Tanaka H et al (2018) Significance of SYT8 for the detection, prediction, and treatment of peritoneal metastasis from gastric cancer. Ann Surg 267:495–503

    Article  PubMed  Google Scholar 

  18. Geng Y, Shao Y, Zhu D et al (2016) Systemic immune-inflammation index predicts prognosis of patients with esophageal squamous cell carcinoma: a propensity score-matched analysis. Sci Rep 6:39482

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Moyes LH, Leitch EF, McKee RF et al (2009) Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 100:1236–1239

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Kim EY, Lee JW, Yoo HM et al (2015) The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio: which is better as a prognostic factor in gastric cancer? Ann Surg Oncol 22:4363–4370

    Article  PubMed  Google Scholar 

  21. Neal CP, Mann CD, Garcea G et al (2011) Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases. Arch Surg 146:471–478

    Article  PubMed  Google Scholar 

  22. Pang W, Lou N, Jin C et al (2016) Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer. Eur J Gastroenterol Hepatol 28:493–502

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Kanda M, Mizuno A, Tanaka C et al (2016) Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer. Medicine (Baltimore) 95:e3781

    Article  CAS  Google Scholar 

  24. Inaoka K, Kanda M, Uda H et al (2017) Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2–4 gastric cancer. World J Gastroenterol 23:2519–2526

    Article  PubMed  PubMed Central  Google Scholar 

  25. Felekis D, Eleftheriadou A, Papadakos G et al (2010) Effect of perioperative immuno-enhanced enteral nutrition on inflammatory response, nutritional status, and outcomes in head and neck cancer patients undergoing major surgery. Nutr Cancer 62:1105–1112

    Article  PubMed  CAS  Google Scholar 

  26. Gonzalez-Torres C, Gonzalez-Martinez H, Miliar A et al (2013) Effect of malnutrition on the expression of cytokines involved in Th1 cell differentiation. Nutrients 5:579–593

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Brenner D, Blaser H, Mak TW (2015) Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol 15:362–374

    Article  PubMed  CAS  Google Scholar 

  28. Kanda M, Fujii T, Kodera Y et al (2011) Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg 98:268–274

    Article  PubMed  CAS  Google Scholar 

  29. Forssell J, Oberg A, Henriksson ML et al (2007) High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 13:1472–1479

    Article  PubMed  CAS  Google Scholar 

  30. Pollard JW (2009) Trophic macrophages in development and disease. Nat Rev Immunol 9:259–270

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10:181–193

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Tokunaga M, Tanizawa Y, Bando E et al (2013) Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol 20:1575–1583

    Article  PubMed  Google Scholar 

  33. Sultan J, Griffin SM, Di Franco F et al (2012) Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery. Br J Surg 99:346–355

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Zhao H, Zhao H, Wang Y et al (2013) Randomized clinical trial of arginine-demented enteral nutrition versus standard enteral nutrition in patients undergoing gastric cancer surgery. J Cancer Res Clin Oncol 139:1465–1470

    Article  PubMed  CAS  Google Scholar 

  35. Wang F, Hou MX, Wu XL et al (2015) Impact of enteral nutrition on postoperative immune function and nutritional status. Genet Mol Res 14:6065–6072

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan

    Bin Sato, Mitsuro Kanda, Chie Tanaka, Daisuke Kobayashi, Naoki Iwata, Norifumi Hattori, Masaya Suenaga, Masamichi Hayashi, Suguru Yamada, Michitaka Fujiwara & Yasuhiro Kodera

  2. Division of Biostatistics, Clinical Research Center, Aichi Medical University Hospital, Nagakute, Japan

    Kenta Murotani

Authors
  1. Bin Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mitsuro Kanda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chie Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daisuke Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Naoki Iwata
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Norifumi Hattori
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masaya Suenaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masamichi Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Suguru Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kenta Murotani
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Michitaka Fujiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yasuhiro Kodera
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitsuro Kanda.

Ethics declarations

Conflict of interest

The authors do not have any commercial interest or sources of financial or material support to report.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sato, B., Kanda, M., Tanaka, C. et al. Significance of Preoperative Systemic Inflammation Score in Short-Term and Long-Term Outcomes of Patients with Pathological T2–4 Gastric Cancer After Radical Gastrectomy. World J Surg 42, 3277–3285 (2018). https://doi.org/10.1007/s00268-018-4597-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-018-4597-7

Search

Navigation